Chemcon Speciality Chemicals Limited
NSE:CHEMCON.NS
283.65 (INR) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 455.214 | 595.913 | 529.807 | 751.93 | 793.271 | 790.826 | 764.712 | 579.195 | 894.114 | 887.631 | 495.402 | 612.406 | 572.054 | 712.181 | 648.064 | 615.37 | 456.656 | 510.104 | 557.313 | 653.407 | 772.592 |
| Cost of Revenue
| 333.624 | 485.764 | 410.293 | 534.543 | 598.947 | 535.91 | 489.58 | 349.903 | 382.044 | 626.439 | 190.034 | 305.152 | 274.943 | 527.909 | 310.867 | 257.105 | 248.05 | 463.319 | 317.981 | 352.011 | 445.03 |
| Gross Profit
| 121.59 | 110.149 | 119.514 | 217.387 | 194.324 | 254.916 | 275.132 | 229.292 | 512.07 | 261.192 | 305.368 | 307.254 | 297.111 | 184.272 | 337.197 | 358.265 | 208.606 | 46.785 | 239.332 | 301.396 | 327.562 |
| Gross Profit Ratio
| 0.267 | 0.185 | 0.226 | 0.289 | 0.245 | 0.322 | 0.36 | 0.396 | 0.573 | 0.294 | 0.616 | 0.502 | 0.519 | 0.259 | 0.52 | 0.582 | 0.457 | 0.092 | 0.429 | 0.461 | 0.424 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0.995 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 75.725 | 91.453 | 81.896 | 83.932 | 40.024 | 64.125 | 90.835 | 84.164 | 56.43 | 54.614 | 49.508 | 47.644 | 75.762 | 97.705 | 46.374 | 37.366 | 31.95 | 37.723 | 31.23 | 34.715 | 38.147 |
| Other Expenses
| 37.646 | 33.38 | 33.423 | 30.324 | 35.871 | 28.858 | 44.585 | 32.885 | 26.818 | -65.048 | 23.311 | 22.506 | 19.419 | -5.341 | 12.151 | 1.419 | 3.438 | -19.674 | 7.779 | 0 | 0 |
| Operating Expenses
| 75.725 | 91.453 | 81.896 | 160.071 | 143.403 | 136.819 | 161.59 | 153.951 | 195.795 | -3.634 | 147.593 | 132.916 | 133.656 | -10.892 | 122.913 | 138.905 | 82.348 | -78.842 | 116.051 | 110.128 | 115.871 |
| Operating Income
| 45.865 | 18.696 | 37.618 | 87.639 | 50.922 | 146.955 | 158.126 | 108.226 | 316.275 | 264.826 | 157.776 | 179.338 | 163.455 | 195.164 | 214.284 | 220.779 | 126.258 | 125.627 | 123.281 | 183.886 | 205.636 |
| Operating Income Ratio
| 0.101 | 0.031 | 0.071 | 0.117 | 0.064 | 0.186 | 0.207 | 0.187 | 0.354 | 0.298 | 0.318 | 0.293 | 0.286 | 0.274 | 0.331 | 0.359 | 0.276 | 0.246 | 0.221 | 0.281 | 0.266 |
| Total Other Income Expenses Net
| 27.795 | 22.855 | 22.999 | -7.256 | 29.103 | -4.884 | -5.893 | -2.465 | 25.174 | 19.182 | 22.262 | 15.969 | 17.149 | 17.837 | 5.807 | -11.834 | -7.738 | 4.52 | -1.299 | -4.375 | -7.086 |
| Income Before Tax
| 73.66 | 41.551 | 60.617 | 80.383 | 80.025 | 142.071 | 152.233 | 105.761 | 341.449 | 284.007 | 180.037 | 195.306 | 180.604 | 213.001 | 220.091 | 208.945 | 118.52 | 130.147 | 121.982 | 179.511 | 198.551 |
| Income Before Tax Ratio
| 0.162 | 0.07 | 0.114 | 0.107 | 0.101 | 0.18 | 0.199 | 0.183 | 0.382 | 0.32 | 0.363 | 0.319 | 0.316 | 0.299 | 0.34 | 0.34 | 0.26 | 0.255 | 0.219 | 0.275 | 0.257 |
| Income Tax Expense
| 19.972 | 12.519 | 16.182 | 21.004 | 20.942 | 37.371 | 38.647 | 27.524 | 86.872 | 71.124 | 45.174 | 49.612 | 46.478 | 57.969 | 55.33 | 53.136 | 30.14 | 32.214 | 29.182 | 43.287 | 47.998 |
| Net Income
| 53.688 | 29.032 | 44.435 | 59.379 | 59.083 | 104.701 | 113.586 | 78.237 | 254.577 | 212.883 | 134.863 | 145.694 | 134.126 | 155.032 | 164.761 | 155.809 | 88.38 | 97.933 | 92.8 | 136.224 | 150.553 |
| Net Income Ratio
| 0.118 | 0.049 | 0.084 | 0.079 | 0.074 | 0.132 | 0.149 | 0.135 | 0.285 | 0.24 | 0.272 | 0.238 | 0.234 | 0.218 | 0.254 | 0.253 | 0.194 | 0.192 | 0.167 | 0.208 | 0.195 |
| EPS
| 1.47 | 0.79 | 1.21 | 1.62 | 1.61 | 2.86 | 3.1 | 2.14 | 6.95 | 5.81 | 3.68 | 3.98 | 3.66 | 4.53 | 4.5 | 4.25 | 2.41 | 2.67 | 2.53 | 4.29 | 4.74 |
| EPS Diluted
| 1.47 | 0.79 | 1.21 | 1.62 | 1.61 | 2.86 | 3.1 | 2.14 | 6.95 | 5.81 | 3.68 | 3.98 | 3.66 | 4.53 | 4.5 | 4.25 | 2.41 | 2.67 | 2.53 | 4.29 | 4.74 |
| EBITDA
| 71.134 | 43.845 | 63.407 | 113.583 | 113.005 | 169.508 | 179.487 | 128.767 | 362.352 | 301.5 | 196.597 | 211.876 | 198.071 | 238.552 | 240.566 | 234.694 | 142.885 | 141.82 | 141.795 | 194.411 | 216.161 |
| EBITDA Ratio
| 0.156 | 0.074 | 0.12 | 0.151 | 0.142 | 0.214 | 0.235 | 0.222 | 0.405 | 0.34 | 0.397 | 0.346 | 0.346 | 0.335 | 0.371 | 0.381 | 0.313 | 0.278 | 0.254 | 0.298 | 0.28 |